{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:35:51Z","timestamp":1795030551846,"version":"4.10.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4610-4","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T08:23:23Z","timestamp":1529915003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":238,"title":["Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study"],"prefix":"10.1186","volume":"18","author":[{"given":"Anas M.","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneer J.","family":"Al-Husseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"issue":"1","key":"4610_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21442\n                    \n                  .","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"4610_CR2","first-page":"7","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: a cancer journal for clinicians. 2016;66(1):7\u201330.","journal-title":"CA: a cancer journal for clinicians."},{"key":"4610_CR3","unstructured":"National Cancer Institute. Estimated new cancer cases and deaths for 2013. SEER (Surveillance Epidemiology and End Results) cancer statistics review. Available from: \n                    http:\/\/www.seer.cancer.gov\n                    \n                  ."},{"issue":"8","key":"4610_CR4","first-page":"626","volume":"89","author":"M De La Cruz","year":"2014","unstructured":"De La Cruz M, Young AP, Ruffin MT. Diagnosis and management of pancreatic cancer. Am Fam Physician. 2014;89(8):626\u201332.","journal-title":"Am Fam Physician."},{"issue":"28","key":"4610_CR5","first-page":"9354","volume":"20","author":"S Mohammed","year":"2014","unstructured":"Mohammed S, George Van Buren I, Fisher WE. Pancreatic cancer: advances in treatment. World Journal of Gastroenterology: WJG. 2014;20(28):9354.","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"4610_CR6","unstructured":"National Research Council (US) Committee on Future Directions for Behavioral and Social Sciences Research at the National Institutes of Health; Singer BH, Ryff CD, editors. New Horizons in Health: An Integrative Approach. Washington (DC): National Academies Press (US); 2001. 8, Population Perspectives: Understanding Health Trends and Evaluating the Health Care System. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK43784\/\n                    \n                  ."},{"issue":"5","key":"4610_CR7","doi-asserted-by":"publisher","first-page":"S1015","DOI":"10.1093\/oxfordjournals.ije.a019904","volume":"28","author":"N Pearce","year":"1999","unstructured":"Pearce N. Epidemiology as a population science. Int J Epidemiol. 1999;28(5):S1015.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4610_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/MPA.0b013e3181bd6489","volume":"39","author":"MK Lau","year":"2010","unstructured":"Lau MK, Davila JA, Shaib YH. Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas. 2010;39(4):458\u201362.","journal-title":"Pancreas"},{"issue":"7","key":"4610_CR9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/annonc\/mdm123","volume":"18","author":"J Zhang","year":"2007","unstructured":"Zhang J, Dhakal I, Yan H, et al. Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973\u20132002. Annals of oncology. 2007;18(7):1268\u201379.","journal-title":"Annals of oncology."},{"key":"4610_CR10","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software (\n                    www.seer.cancer.gov\/seerstat\n                    \n                  ) version 8.3.4."},{"key":"4610_CR11","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (\n                    www.seer.cancer.gov\n                    \n                  ) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2016 Sub (1973-2014) <Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission."},{"issue":"12","key":"4610_CR12","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/0895-4356(94)90089-2","volume":"47","author":"KC Chu","year":"1994","unstructured":"Chu KC, Miller BA, Feuer EJ, et al. A method for partitioning cancer mortality trends by factors associated with diagnosis: An application to female breat cancer. J Clin Epidemiol. 1994;47(12):1451\u201361.","journal-title":"J Clin Epidemiol"},{"key":"4610_CR13","unstructured":"Joinpoint Regression Program, Version 4.5.0.1. June, 2017; Statistical Research and Applications Branch, National Cancer Institute. \n                    https:\/\/surveillance.cancer.gov\/joinpoint\/\n                    \n                  . Last Accessed on 26\/7\/2017."},{"issue":"3","key":"4610_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"H-J Kim","year":"2000","unstructured":"Kim H-J, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine. 2000;19(3):335\u201351.","journal-title":"Statistics in medicine."},{"issue":"11","key":"4610_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371(11):1039\u201349.","journal-title":"N Engl J Med"},{"issue":"5","key":"4610_CR16","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.2910610507","volume":"61","author":"T Zheng","year":"1995","unstructured":"Zheng T, Holford TR, Ward BA, et al. Time trend in pancreatic cancer incidence in Connecticut, 1935\u20131990. Int J Can. 1995;61(5):622\u20137.","journal-title":"Int J Can"},{"issue":"8","key":"4610_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1365-2036.2006.02860.x","volume":"23","author":"H Wood","year":"2006","unstructured":"Wood H, Gupta S, Kang J, et al. Pancreatic cancer in England and Wales 1975\u20132000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther. 2006;23(8):1205\u201314.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"4610_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00006676-200308000-00006","volume":"27","author":"F Levi","year":"2003","unstructured":"Levi F, Lucchini F, Negri E, et al. Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas. 2003;27(2):139\u201342.","journal-title":"Pancreas."},{"issue":"1","key":"4610_CR19","first-page":"9","volume":"34","author":"M Pericleous","year":"2014","unstructured":"Pericleous M, Rossi RE, Mandair D, et al. Nutrition and pancreatic cancer. Anticancer Res. 2014;34(1):9\u201321.","journal-title":"Anticancer Res"},{"key":"4610_CR20","doi-asserted-by":"crossref","unstructured":"Conroy T, Desseigne F, Ychou M, et al. Randomized phase III trial comparing FOLFIRINOX (F: 5FU\/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): preplanned interim analysis results of the PRODIGE 4\/ACCORD 11 trial. J Clin Oncol. 2010;28(15_suppl):4010-4010.","DOI":"10.1200\/jco.2010.28.15_suppl.4010"},{"issue":"2","key":"4610_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bpg.2005.10.001","volume":"20","author":"AB Lowenfels","year":"2006","unstructured":"Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):197\u2013209.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"4610_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1015052710213","volume":"13","author":"Y Lin","year":"2002","unstructured":"Lin Y, Tamakoshi A, Kawamura T, et al. A prospective cohort study of cigarette smoking and pancreatic cancer in Japan. Cancer Causes and Control. 2002;13(3):249\u201354.","journal-title":"Cancer Causes and Control."},{"issue":"4","key":"4610_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","volume":"393","author":"S Iodice","year":"2008","unstructured":"Iodice S, Gandini S, Maisonneuve P, et al. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbeck's Archives of Surgery. 2008;393(4):535\u201345.","journal-title":"Langenbeck's Archives of Surgery."},{"issue":"3","key":"4610_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/sj.bjc.6601140","volume":"89","author":"AB de Gonzalez","year":"2003","unstructured":"de Gonzalez AB, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer Suppl. 2003;89(3):519.","journal-title":"Br J Cancer Suppl"},{"key":"4610_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965","volume-title":"Helicobacter pylori seropositivities and risk of pancreatic carcinoma","author":"HA Risch","year":"2014","unstructured":"Risch HA, Lu L, Kidd MS, Wang J, Zhang W, Ni Q, Gao YT, Yu H. Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Biomarkers & Prevention: Cancer Epidemiology; 2014. \n                    https:\/\/doi.org\/10.1158\/1055-9965\n                    \n                  ."},{"key":"4610_CR26","doi-asserted-by":"publisher","unstructured":"Schulte A, Pandeya N, Fawcett J, Fritschi L, Risch HA, Webb PM, Whiteman DC, Neale RE. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes & Control. 2015; \n                    https:\/\/doi.org\/10.1007\/s10552-015-0595-3\n                    \n                  .","DOI":"10.1007\/s10552-015-0595-3"},{"issue":"5","key":"4610_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/13651820802291233","volume":"10","author":"A Artinyan","year":"2008","unstructured":"Artinyan A, Soriano PA, Prendergast C, et al. The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB. 2008;10(5):371\u20136.","journal-title":"HPB."},{"key":"4610_CR28","doi-asserted-by":"publisher","unstructured":"Barreto SG, Shukla PJ, Shrikhande SV. Tumors of the Pancreatic Body and Tail. World J Oncol. 2010; \n                    https:\/\/doi.org\/10.4021\/wjon2010.04.200w\n                    \n                  .","DOI":"10.4021\/wjon2010.04.200w"},{"issue":"3","key":"4610_CR29","first-page":"288","volume":"23","author":"BYM James","year":"2009","unstructured":"James BYM, Gross CP, Wilson LD, et al. NCI SEER public-use data: applications and limitations in oncology research. Oncology. 2009;23(3):288.","journal-title":"Oncology"},{"issue":"9","key":"4610_CR30","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","volume":"54","author":"A-M Noone","year":"2016","unstructured":"Noone A-M, Lund JL, Mariotto A, et al. Comparison of SEER treatment data with Medicare claims. Medical care. 2016;54(9):e55.","journal-title":"Medical care"},{"issue":"11","key":"4610_CR31","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research. 2014;74(11):2913\u201321.","journal-title":"Cancer research."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4610-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T19:06:12Z","timestamp":1561403172000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4610-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4610"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4610-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"assertion":[{"value":"12 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We got approval from the National Cancer Institute to use data of patient from SEER database. Participant consent was not necessary as this study involved the use of a previously-published de-identified database according to SEER database.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"688"}}